PDF 362 KB
Frequently answered questions on MRSA targeted at the health care professionals
Staphylococcus aureus (S. aureus) is a bacterium that can commonly live on the skin or in the nose or mouth of people (colonisation) that causes community and healthcare related infections around the world.
Some strains of S. aureus have developed resistance to antibiotics, and these are known as methicillin-resistant Staphylococcus aureus (MRSA). MRSA are resistant to methicillin (a derivative of penicillin) and other closely related antibiotics (oxacillin, flucloxacillin). They may also be resistant to a number of other antibiotics (sometimes referred to as multi-resistant strains).
People with MRSA colonisation can be asymptomatic. The pathogenic potential of S. aureus ranges from mild skin infections (for example boils) to serious deep infection such as osteomyelitis, and potentially fatal systemic illness such as bloodstream infection.
MRSA are important hospital pathogens that can cause significant infections in susceptible patients.
In hospital, people who have lowered resistance or who have breaks in their skin due to surgery, indwelling devices or chronic wounds, may be predisposed to either MRSA colonisation or infection.
Numerous reports of hospital outbreaks of MRSA have shown that patient-to-patient transmission of MRSA is common. The most likely modes of transmission are:
Patients who are colonised may also self-infect areas of broken skin, or medical device insertion sites.
The prevention of infection with MRSA involves the simultaneous application of a number of strategies:
Hospitals and healthcare settings should have a strategy for management of MRSA colonisation and infection with practices adapted to suit the clinical setting. For example, management of patients identified with MRSA in an intensive care unit may be different to management of a patient attending an outpatient department where the risk of transmission and infection are lower.
Some patients may benefit from decolonisation treatment with mupirocin nasal ointment and medicated body washes. See the Staphylococcus aureus Patient Decolonisation consumer information fact sheet (PDF 363KB).
For further information on MRSA see the MRSA Guideline (PDF 766KB), the MRSA healthcare worker fact sheet (PDF 71KB) or contact SA Health's Infection Control Service.